<DOC>
	<DOCNO>NCT02153398</DOCNO>
	<brief_summary>The objective study ass safety , pharmacokinetics , pharmacodynamics efficacy repeat daily oral administration D961H 10 mg D961H 20 mg Japanese paediatric patient age 1 14 year old either diagnosis suspect gastric ulcer ( GU ) , duodenal ulcer ( DU ) , anastomotic ulcer ( AU ) , non-erosive reflux esophagitis disease ( NERD ) , reflux esophagitis ( RE ) Zollinger-Ellison syndrome .</brief_summary>
	<brief_title>A Phase I/III Study D961H 10 mg 20 mg Japanese Paediatric Patients With Gastrointestinal Acid Related Diseases</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Esophagitis</mesh_term>
	<mesh_term>Duodenal Ulcer</mesh_term>
	<mesh_term>Esophagitis , Peptic</mesh_term>
	<mesh_term>Stomach Ulcer</mesh_term>
	<mesh_term>Zollinger-Ellison Syndrome</mesh_term>
	<mesh_term>Gastrinoma</mesh_term>
	<criteria>Provision sign write informed consent patient 's guardian Patients age â‰¥ 1 year 14 year old Patients diagnosis suspect GU , DU , AU , NERD , RE ZollingerEllison syndrome . Patients less 10 kg weight . Use investigational compound participation another clinical trial within 4 week prior randomisation/registration . Significant clinical illness within 4 week prior registration Presence hepatic disease condition could interfere evaluation study judge investigator . Positive pregnancy test urinary lactation postmenarchal female . Previous total gastrectomy</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>14 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Gastric ulcer ( GU )</keyword>
	<keyword>Duodenal ulcer ( DU )</keyword>
	<keyword>Anastomotic ulcer ( AU )</keyword>
	<keyword>Non-erosive reflux esophagitis disease ( NERD )</keyword>
	<keyword>Reflux esophagitis ( RE )</keyword>
	<keyword>Zollinger-Ellison syndrome</keyword>
</DOC>